Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026
Syndax Pharmaceuticals, a commercial-stage biopharmaceutical company specializing in cancer therapies, announced its plan to release its second quarter 2026 financial results on August 4, 2026, followed by a conference call and webcast. The company highlighted its FDA-approved products Revuforj® and Niktimvo™ and ongoing clinical trials as part of …